Evidence map›Paper›PMID 32166483›Full record

ReviewWorld journal of pediatrics : WJP2020

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.

Yan Wang, Li-Qin Zhu

Abstract readReview
In one paragraph

Review in World journal of pediatrics : WJP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. What you need to know about children's COVID-19: a systematic review.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2021
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. COVID-19; current situation and recommended interventions.International journal of clinical practice · 2021
    Review
  11. COVID-19 Management in Pediatrics.The journal for nurse practitioners : JNP · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. The Trilogy of SARS-CoV-2 in Pediatrics (Part 1): Acute COVID-19 in Special Populations.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Yan WangDepartment of Pharmacy, Tianjin Children's Hospital, Tianjin 300134, China.
Li-Qin ZhuDepartment of Pharmacy, Tianjin First Central Hospital, Tianjin 300192, China. zlq0713@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pharmaceutical ServicesPractice Guidelines as TopicAdolescentAge FactorsAntiviral AgentsChildChild, PreschoolChinaChloroquineCoronavirus InfectionsCOVID-19FemaleHumansIndolesInfantInfant, NewbornAntiviral AgentsChloroquinechloroquine diphosphateIndolesInterferon-alphaLopinavirRibavirinSulfidesumifenovir

Identifiers

PMID32166483
PMCPMC7090514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.